Hormone replacement therapy in women with cancer and risk of cancer-specific mortality and cardiovascular disease: a protocol for a cohort study from Scotland and Wales

被引：0
|
作者：
Úna McMenamin
Blánaid Hicks
Carmel Hughes
Peter Murchie
Julia Hippisley-Cox
Tom Ranger
Carol Coupland
Chris Cardwell
机构：
[1] Queen’s University Belfast,Centre for Public Health, ICSB
[2] Queen’s University Belfast,School of Pharmacy
[3] Academic Primary Care,Division of Applied Health Sciences Section
[4] University of Oxford,Primary Care Epidemiology, Nuffield Department of Primary Care Health Sciences, Medical Sciences Division
[5] University of Nottingham,Division of Primary Care
来源：
BMC Cancer | / 21卷
关键词：
Cancer; Hormone replacement therapy; Mortality; Cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Hormone replacement therapy in women with cancer and risk of cancer-specific mortality and cardiovascular disease: a protocol for a cohort study from Scotland and Wales
    McMenamin, Una
    Hicks, Blanaid
    Hughes, Carmel
    Murchie, Peter
    Hippisley-Cox, Julia
    Ranger, Tom
    Coupland, Carol
    Cardwell, Chris
    [J]. BMC CANCER, 2021, 21 (01)
  • [2] Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men
    Siltari, Aino
    Murtola, Teemu J.
    Kausz, Josefina
    Talala, Kirsi
    Taari, Kimmo
    Tammela, Teuvo L. J.
    Auvinen, Anssi
    [J]. ACTA ONCOLOGICA, 2023, 62 (12) : 1898 - 1904
  • [3] Hormone replacement therapy and lung cancer risk in women: a meta-analysis of cohort studies Hormone replacement therapy and lung cancer risk
    Jin, Chao
    Lang, Baoping
    [J]. MEDICINE, 2019, 98 (51)
  • [4] Cardiovascular disease mortality among women with endometrial cancer: A retrospective cohort study based in Scotland.
    Wild, S
    Bryden, J
    Lee, R
    Bishop, J
    Finlayson, A
    Brewster, D
    [J]. CIRCULATION, 2005, 111 (04) : E47 - E47
  • [5] Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women
    de Lignières, B
    de Vathaire, F
    Fournier, S
    Urbinelli, R
    Allaert, F
    Le, MG
    Kuttenn, F
    [J]. CLIMACTERIC, 2002, 5 (04) : 332 - 340
  • [6] Hormone replacement therapy and cancer survival: a longitudinal cohort study: protocol paper
    Ranger, Tom Alan
    Burchardt, Judith
    Clift, Ashley Kieran
    Mei, Winnie Xue
    Coupland, Carol
    Tan, Pui San
    Dixon, Sharon
    Cardwell, Christopher Robert
    Hippisley-Cox, Julia
    [J]. BMJ OPEN, 2021, 11 (08):
  • [7] Hormone replacement therapy in women with SLE and risk of cardiovascular disease
    Hochman, J
    Ibanez, D
    Urowitz, M
    Gladman, D
    [J]. JOURNAL OF RHEUMATOLOGY, 2005, 32 (07) : 1396 - 1396
  • [8] Hormone replacement therapy in women with SLE and risk of cardiovascular disease
    Hochman, J
    Ibanez, D
    Urowitz, M
    Gladman, D
    [J]. JOURNAL OF RHEUMATOLOGY, 2006, 33 (02) : 391 - 391
  • [9] Hormone replacement therapy and cancer mortality in women with 17 site-specific cancers: a cohort study using linked medical records
    Cardwell, Chris R.
    Ranger, Tom A.
    Labeit, Alexander M.
    Coupland, Carol A. C.
    Hicks, Blanaid
    Hughes, Carmel
    Mcmenamin, Una
    Mei, Xue W.
    Murchie, Peter
    Hippisley-Cox, Julia
    [J]. BRITISH JOURNAL OF CANCER, 2024, 131 (04) : 737 - 746
  • [10] RISK OF CANCER IN WOMEN RECEIVING HORMONE REPLACEMENT THERAPY
    ADAMI, HO
    PERSSON, I
    HOOVER, R
    SCHAIRER, C
    BERGKVIST, L
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (05) : 833 - 839
12345